vimarsana.com
Home
Live Updates
Additional US$ 4 Million Received for Next Development Steps
Additional US$ 4 Million Received for Next Development Steps
Additional US$ 4 Million Received for Next Development Steps of MedinCell's 6-Month Active Injectable Bioresorbable Subcutaneous Contraceptive
Regulatory News: MedinCell (Paris:MEDCL) has received an additional US$ 4 million payment from the Bill Melinda Gates Foundation This amount is intended to finance the next steps of MedinCell's
Related Keywords
United States ,
France ,
Christophe Douat ,
Nicolas Merigeau ,
Helen Martin ,
David Heuz ,
Louis Victor Delouvrier Olivier Bricaud ,
Head Of Communications ,
Melinda Gates Foundation To Medincell ,
Global Health ,
Guttmacher Institute ,
Melinda Gates Foundation ,
Gates Foundation ,
Regulatory News ,
Bill Melinda Gates ,
Bill Melinda Gates Foundation ,
Global Access ,
Long Acting Reversible Contraceptives ,
Des March ,
Additional ,
Billion ,
Eceived ,
Text ,
Development ,
Steps ,
Medincell ,
Month ,
Ctive ,
Injectable ,
Bioresorbable ,
Subcutaneous ,
Contraceptive ,